Phonak AG, Switzerland
9
0
0
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
29%
2 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Remote Microphone Candidacy Study
Role: collaborator
Evaluation of New Custom Made Hearing Product Technology and Shell Modification
Role: lead
Evaluation of Frequency Lowering Technique
Role: lead
Hearing Instruments in Alzheimer's Disease
Role: lead
Real-Ear Measurement (REM) and Test Box System Integration Into Fitting Software
Role: lead
Performance of a Hearing Aid Platform Including Different Styles of Hearing Aids
Role: lead
Optimization of Music Compression
Role: lead
Post-market Study to Capture Information Regarding Performance of Lyric2
Role: lead
The Phonak EduLink-System in Students With Specific Performance Deficits in Speech-in-Noise Intelligibility
Role: collaborator
All 9 trials loaded